ROBERT ALLISON: Open Payments
NPI 1164753810 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$598 in 26 payments from 8 companies in 2025. Trend: 2023 $1,375 · 2024 $1,960 · 2025 $598
Food & beverage: $513Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $201 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| ABBVIE INC. | 3 | $63 |
| Phathom Pharmaceuticals, Inc. | 2 | $60 |
| Aimmune Therapeutics, Inc. | 3 | $48 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Ferring Pharmaceuticals Inc. | 1 | $24 |
Products named: TREMFYA, XIFAXAN, VOQUEZNA, ENTYVIO, ZENPEP, RINVOQ, Enhertu, EOHILIA.
Industry payments across PA — which companies pay providers there.
